Loading company details...
Beta
Latest Form 4 (Sep 23, 2026): Jeffrey W. Baumgartner (EVP, R&D): Sale of 1,166 shares, $138.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2026 | Jeffrey W. Baumgartner, EVP, R&D | Sale | 1,166 | $138.8K |
| Aug 24, 2026 | Jeffrey W. Baumgartner, EVP, R&D | Sale | 1,166 | $137.5K |
| Jul 31, 2026 | David J. Tupman | Grant/Award | 1,998 | n/a |
| Jul 31, 2026 | William D. Mosley | Grant/Award | 1,998 | n/a |
| Jul 31, 2026 | Catherine P. Lego | Grant/Award | 1,998 | n/a |
| Jul 31, 2026 | Duy Loan T. Le | Exercise/Conversion | 1,998 | n/a |
| Jul 31, 2026 | Muhammad Raghib Hussain | Grant/Award | 1,998 | n/a |
| Jul 31, 2026 | Alexander M. Davern | Grant/Award | 1,998 | n/a |
| Jul 21, 2026 | Jeffrey W. Baumgartner, EVP, R&D | Sale | 1,166 | $161.6K |
| Jul 2, 2026 | Jeffrey W. Baumgartner, EVP, R&D | Exercise/Conversion | 1,458 | $100.0K |